Hence, vaccinating against the S protein generates neutralizing antibodies and abrogates SARS-CoV-2 entry, making the S protein one of the most favorable targets in COVID-19 vaccine designs (Dai and Gao, 2021). The gene discussed is PROS1; the disease is COVID-19.